Christopher Sullivan
Net worth: 611 667 $ as of 2026-09-29
Net worth: 611 667 $ as of 2026-09-29
Christopher Sullivan is currently Chief Financial Officer at Avalo Therapeutics, Inc. since 2022.
Formerly, Mr. Sullivan was Controller at Sucampo Pharmaceuticals LLC from 2017 to 2018, Controller at CapForce, Inc. from 2015 to 2017, and Senior Manager at Ernst & Young LLP.
Mr. Sullivan completed undergraduate studies at the University of Maryland.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-15 | 39,900 ( 0.07% ) | 611 667 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 2022-02-13 |
| Companies | Position | End |
|---|---|---|
| SUCAMPO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2018-03-31 |
| CAPFORCE INC. | Comptroller/Controller/Auditor | 2017-07-31 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
OpGen, Inc.
OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions